Figure 1 illustrates the process of identifying and including articles, following the PRISMA-ScR® guidelines. Initially, 403 articles were considered for potential inclusion in the study, which 30 articles were included in this review [7, 10, 12, 18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44].

PRISMA flow diagram (2020) [16]

Although the search was conducted without time restrictions, 30 studies published between 2011 and 2023 were included. The studies were conducted in various countries, with the highest incidence in the United States (n = 9) [12, 23, 31, 35, 36, 38, 39, 44]. Regarding methodology, 18 studies described the development of digital solutions [12, 21, 23,24,25, 27, 30,31,32,33,34,35,36,37, 39, 41, 42], 10 studies conducted implementation or usability/feasibility trials [12, 18, 20, 31, 32, 35, 37, 38, 40, 43], and 8 studies evaluated the impact on adherence, health literacy, or self-care [12, 23, 25, 31, 35, 38, 39, 44]. It is important to note that several studies incorporated more than one of these objectives (Table 1).

The 30 studies included in this review involved a total of 1,118 participants in those studies that reported these data [12, 23, 31, 34, 35, 38,39,40, 43, 44]. Most participants were adults diagnosed with oncological diseases at different stages of the clinical pathway [12, 23, 31, 35, 38,39,40, 43, 44]. Some studies specifically targeted children and adolescents with cancer [21, 34, 39, 44], while others included older adults or mixed populations [34, 35, 38,39,40]. Cancer survivors with different types of malignancies were included. Breast cancer was the most frequent diagnosis among the studies [12, 31, 35, 44], followed by cases of lung cancer [30, 33], head and neck cancer [37], prostate cancer [41], as well as gastrointestinal cancer, melanoma, and leukemia [32, 36, 43]. Pediatric cancer was also represented, with several studies focusing on children and adolescents [